Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 3/20 | 0.50 |
| ▸ | ARG1 | P05089 | 2/20 | 0.40 |
| ▸ | ARG2 | P78540 | 2/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 7/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.35 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.35 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13965722 | 1.00 | OPRD1 (0.50) | OPRD1ARG1ARG2HRH3FFAR1 | |
| SCHEMBL13656349 | 0.80 | SPHK2 (0.46) | ARG1ARG2HRH3S1PR4S1PR1 | |
| SCHEMBL13656348 | 0.80 | SPHK2 (0.46) | ARG1ARG2HRH3S1PR4S1PR1 | |
| SCHEMBL8136699 | 0.80 | SPHK2 (0.46) | ARG1ARG2HRH3S1PR4S1PR1 | |
| SCHEMBL13974956 | 0.79 | OPRD1 (0.69) | OPRD1S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL8136742 | 0.78 | ATM (0.36) | ARG1ARG2HRH3S1PR4S1PR1 | |
| SCHEMBL7021680 | 0.78 | ALDH1A1 (0.53) | OPRD1FFAR1 | |
| SCHEMBL13965718 | 0.77 | LMNA (0.46) | LTA4H | |
| SCHEMBL13965721 | 0.77 | LMNA (0.46) | LTA4H | |
| SCHEMBL12156772 | 0.77 | LMNA (0.46) | LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120295903-A1 | FLAVIN DERIVATIVES | BLOUNT KENNETH F (US) | 2012-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120295903-A1 | FLAVIN DERIVATIVES | BLVRB, FLAD1, FDPS | OPRD1 3096/4885ARG1 4545/4885ARG2 3149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.